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Process characterization is a critical phase in the development of a commercial process for biotherapeutic 
production. Knowing the critical quality attributes of your molecule prior to beginning process development 
and/or characterization is imperative when using a quality by design (QbD) approach. Here we use a (QbD) 
approach for the characterization of a fed-batch process using an NSO cell line to express an IgG. For this 
molecule, the glycosylation profile, and in particular, the total fucosylation was identified as a critical quality 
attribute. After performing a primary hazard analysis, several process inputs were determined to potentially have 
an impact on this critical quality attribute. These parameters were then studied in a screening DoE using the 
ambr15™ to model the first and second order effects for each parameter on both the critical quality attributes 
and process performance. Of the 9 parameters studied, 5 were determined to have a statistically significant 
effect on the fucosylation of the molecule. In addition, 6 parameters were identified to have a significant impact 
on process performance. Through process modeling using JMP, a design space was determined for further 
studies to determine the proven acceptable range (PAR) for each parameter using the 10L, qualified scale down 
model. An example of the predicted PAR for pH and the timing of the temp shift can be seen in figure 1. 
Following the 10L studies, a PAR was determined for each parameter and compared with the predicted PAR 
from ambr. Here we demonstrate the feasibility to use the ambr15™ as a tool for key and even critical process 
parameter identification to reduce timelines for process characterization. 
 
 
 
 Figure 1 – Design space for critical process 
parameters satisfying the critical quality 
attributes of an IgG 
